Neuromuscular Disease News and Research

RSS
Advanced understanding of neurodegenerative diseases achieved by Trophos

Advanced understanding of neurodegenerative diseases achieved by Trophos

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Diabetic Neuropathy: An interview with Dr Brian Callaghan

New understanding of how motor neurons die in spinal muscular atrophy patients

New understanding of how motor neurons die in spinal muscular atrophy patients

DYNC1H1 genetic mutation contributes to SMA-LED

DYNC1H1 genetic mutation contributes to SMA-LED

Research grants on facioscapulohumeral dystrophy prove useful as genetic basis is found

Research grants on facioscapulohumeral dystrophy prove useful as genetic basis is found

Ultragenyx reports results from UX001 Phase 1 study on HIBM

Ultragenyx reports results from UX001 Phase 1 study on HIBM

UIC researcher to explore causes of myasthenia gravis

UIC researcher to explore causes of myasthenia gravis

Positive results from Repligen's RG3039 Phase 1 study for spinal muscular atrophy

Positive results from Repligen's RG3039 Phase 1 study for spinal muscular atrophy

Genetically modified mouse mimics key features of Charcot-Marie-Tooth disease

Genetically modified mouse mimics key features of Charcot-Marie-Tooth disease

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

Invasive strategy benefits patients with myotonic dystrophy type 1 neuromuscular disorder

Invasive strategy benefits patients with myotonic dystrophy type 1 neuromuscular disorder

TACT believes that Halo's HT-100 may effectively treat DMD

TACT believes that Halo's HT-100 may effectively treat DMD

Ultragenyx completes UX001 Phase 1 study on hereditary inclusion body myopathy

Ultragenyx completes UX001 Phase 1 study on hereditary inclusion body myopathy

Prosensa secures €23M in new equity financing

Prosensa secures €23M in new equity financing

Four Loyola anesthesiologists have written chapters for Manual of Clinical Anesthesiology

Four Loyola anesthesiologists have written chapters for Manual of Clinical Anesthesiology

Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model

Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model

People with myotonic muscular dystrophy more likely to develop cancer

People with myotonic muscular dystrophy more likely to develop cancer

ACGME approves Cedars-Sinai's neurology residency training program

ACGME approves Cedars-Sinai's neurology residency training program

Health supplement hope for child muscle disease

Health supplement hope for child muscle disease